A phase II trial of high‐dose cisplatin and dacarbazine. Lack of efficacy of high‐dose, cisplatin‐based therapy for metastatic melanoma
Steffens, Thomas A., Bajorin, Dean F., Chapman, Paul B., Lovett, David R., Cody‐Johnson, Beverly V., Templeton, Mary Agnes, Heelan, Robert T., Wong, George Y., Portlock, Carol S., Oettgen, Herbert F., Houghton, Alan N.
Published in Cancer (15.09.1991)
Published in Cancer (15.09.1991)
Get full text
Journal Article